Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 261 - 280 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13 14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Cerevance Achieves First Milestone in Research Collaboration with Merck

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Cerevance Inc. | Cerevance Inc.

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  GlucoTrack Inc

ASLAN Pharmaceuticals Announces Expansion of its Collaboration With Zenyaku to Investigate the Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  ASLAN Pharmaceuticals Ltd.

Outlook Therapeutics® to Present at the Retina World Congress 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Outlook Therapeutics, Inc.

Kriya Announces Three Presentations at the 2024 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Kriya Therapeutics

KFSH&RC Ranked Top Valuable Healthcare Brand in Saudi Arabia and Middle East

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  King Faisal Specialist Hospital & Research Centre

Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer and Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Aprea Therapeutics, Inc.

Genmab Announces Financial Results for the First Quarter of 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Genmab A/S

Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in Europe

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Crossject

Number of voting rights as of April 30, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Nicox S.A.

Acentra Health Executive Vice President & Chief Strategy Officer Verlon Johnson Appointed Chair of Medicaid and CHIP Payment Access Commission

Read more ››
By: GlobeNewswire - 02 May 2024

Ibogaine By David Dardashti Pioneers Work on Quantum Electrodynamics Prototype

Read more ››
By: GlobeNewswire - 02 May 2024

Retrieve Medical Announces Significant Results from Physician Burnout Study

Read more ››
By: GlobeNewswire - 02 May 2024

AB Science : The Paris Court of Appeal confirms the acquittal of the CEO of AB Science, Alain Moussy, and reduces the amount of the financial penalty imposed on AB Science

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  AB Science SA | AllianceBernstein L.P.

ALK upgrades its full-year revenue outlook

Read more ››
By: GlobeNewswire - 02 May 2024

Three-month interim report (Q1) 2024 (unaudited) 

Read more ››
By: GlobeNewswire - 02 May 2024

AdCare Rhode Island Unveils Plans for New Addition After Devastating Fire

Read more ››
By: GlobeNewswire - 02 May 2024

Park Systems Announces 2024 NANOscientific Symposiums

Read more ››
By: PR Newswire Association LLC. - 02 May 2024

Inspira™ Announces Start of Production of the INSPIRA™ ART100

Read more ››
By: PR Newswire Association LLC. - 02 May 2024
Related companies:  Inspira Technologies

Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference

Read more ››
By: PR Newswire Association LLC. - 02 May 2024
Related companies:  Acurx Pharmaceuticals, LLC
«  1  2  3  4  5  6  7  8  9  10  11  12  13 14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑